Growth Metrics

Forte Biosciences (FBRX) Net Margin (2016 - 2020)

Historic Net Margin for Forte Biosciences (FBRX) over the last 5 years, with Q1 2020 value amounting to 1242.72%.

  • Forte Biosciences' Net Margin rose 1910649500.0% to 1242.72% in Q1 2020 from the same period last year, while for Dec 2020 it was 1242.72%, marking a year-over-year increase of 1776760600.0%. This contributed to the annual value of 176433.33% for FY2019, which is 1761619000.0% down from last year.
  • According to the latest figures from Q1 2020, Forte Biosciences' Net Margin is 1242.72%, which was up 1910649500.0% from 117588.89% recorded in Q4 2019.
  • Over the past 5 years, Forte Biosciences' Net Margin peaked at 1797.8% during Q3 2016, and registered a low of 217811.11% during Q4 2018.
  • In the last 5 years, Forte Biosciences' Net Margin had a median value of 99530.0% in 2017 and averaged 90253.87%.
  • Per our database at Business Quant, Forte Biosciences' Net Margin crashed by 2000000000bps in 2019 and then soared by 1910649500bps in 2020.
  • Over the past 5 years, Forte Biosciences' Net Margin (Quarter) stood at 1620.88% in 2016, then plummeted by -6786bps to 108370.0% in 2017, then tumbled by -101bps to 217811.11% in 2018, then surged by 46bps to 117588.89% in 2019, then skyrocketed by 101bps to 1242.72% in 2020.
  • Its Net Margin stands at 1242.72% for Q1 2020, versus 117588.89% for Q4 2019 and 208166.67% for Q3 2019.